HEADER HYDROLASE 15-MAY-22 7ZVF TITLE CRYSTAL STRUCTURE OF HUMAN CATHEPSIN L IN COMPLEX WITH COVALENTLY TITLE 2 BOUND CLIK148 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN L; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSL, CTSL1; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PHAFFII GS115; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 644223 KEYWDS CYSTEIN PROTEASE, DRUG TARGET, LYSOSOME, VIRUS CELL ENTRY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.FALKE,J.LIESKE,S.GUENTHER,P.Y.A.REINKE,W.EWERT,J.LOBODA,K.KARNICAR, AUTHOR 2 A.USENIK,N.LINDIC,A.SEKIRNIK,H.TSUGE,H.N.CHAPMAN,W.HINRICHS,D.TURK, AUTHOR 3 A.MEENTS REVDAT 4 23-OCT-24 7ZVF 1 REMARK REVDAT 3 22-MAY-24 7ZVF 1 JRNL REVDAT 2 15-MAY-24 7ZVF 1 JRNL REVDAT 1 29-NOV-23 7ZVF 0 JRNL AUTH S.FALKE,J.LIESKE,A.HERRMANN,J.LOBODA,K.KARNICAR,S.GUNTHER, JRNL AUTH 2 P.Y.A.REINKE,W.EWERT,A.USENIK,N.LINDIC,A.SEKIRNIK,K.DRETNIK, JRNL AUTH 3 H.TSUGE,V.TURK,H.N.CHAPMAN,W.HINRICHS,G.EBERT,D.TURK, JRNL AUTH 4 A.MEENTS JRNL TITL STRUCTURAL ELUCIDATION AND ANTIVIRAL ACTIVITY OF COVALENT JRNL TITL 2 CATHEPSIN L INHIBITORS. JRNL REF J.MED.CHEM. V. 67 7048 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38630165 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02351 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18-3861_9999 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 99347 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1957 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.3300 - 3.8600 0.94 6889 140 0.1557 0.1712 REMARK 3 2 3.8600 - 3.0600 0.97 7166 149 0.1606 0.1450 REMARK 3 3 3.0600 - 2.6700 0.97 7189 141 0.1648 0.2019 REMARK 3 4 2.6700 - 2.4300 0.89 6551 130 0.1571 0.1706 REMARK 3 5 2.4300 - 2.2600 0.95 7015 141 0.1564 0.1844 REMARK 3 6 2.2600 - 2.1200 0.96 7090 144 0.1586 0.1953 REMARK 3 7 2.1200 - 2.0200 0.96 7131 141 0.1591 0.2118 REMARK 3 8 2.0200 - 1.9300 0.97 7100 140 0.1624 0.2072 REMARK 3 9 1.9300 - 1.8500 0.89 6613 134 0.1741 0.2270 REMARK 3 10 1.8500 - 1.7900 0.92 6706 140 0.1813 0.2163 REMARK 3 11 1.7900 - 1.7300 0.94 6998 129 0.1907 0.2807 REMARK 3 12 1.7300 - 1.6800 0.95 6951 151 0.1893 0.2268 REMARK 3 13 1.6800 - 1.6400 0.95 7024 119 0.1971 0.2408 REMARK 3 14 1.6400 - 1.6000 0.94 6967 158 0.2093 0.2676 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.164 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.268 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 7333 REMARK 3 ANGLE : 1.058 9867 REMARK 3 CHIRALITY : 0.053 960 REMARK 3 PLANARITY : 0.023 1306 REMARK 3 DIHEDRAL : 23.338 2676 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292122991. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 100813 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 44.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.4 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.13-2998_9999 REMARK 200 STARTING MODEL: 3OF9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MATURE CATHEPSIN L AT A CONCENTRATION REMARK 280 OF 7 MG/ML WAS EQUILIBRATED AGAINST 27% W/V PEG 8000, 1 MM TCEP REMARK 280 AND 0.1 M SODIUM ACETATE AT PH 4.0. CRYSTALS, WHICH GREW AT 293 REMARK 280 K TO FINAL SIZE AFTER APPROXIMATELY 3 DAYS, WERE TRANSFERRED TO REMARK 280 A COMPOUND SOAKING SOLUTION CONTAINING 22% W/V PEG 8000, 1 MM REMARK 280 TCEP AND 0.1 M SODIUM ACETATE AT PH 4.0 AS WELL AS 5% V/V DMSO REMARK 280 AND 10% V/V PEG 400., VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 117 OE2 GLU B 159 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 71 OE2 GLU B 176 1445 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 206 NH1 - CZ - NH2 ANGL. DEV. = -7.5 DEGREES REMARK 500 ARG A 206 NE - CZ - NH1 ANGL. DEV. = 7.7 DEGREES REMARK 500 ARG A 206 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 205 57.18 -118.62 REMARK 500 ALA A 214 58.64 -147.35 REMARK 500 ALA B 214 56.08 -148.10 REMARK 500 ALA C 214 58.31 -145.44 REMARK 500 ASP D 160 68.54 -113.48 REMARK 500 SER D 174 -168.82 70.26 REMARK 500 ARG D 205 51.13 -118.64 REMARK 500 ALA D 214 57.18 -146.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 305 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 178 OD2 REMARK 620 2 GLN B 75 OE1 127.7 REMARK 620 3 GLN B 78 OE1 121.0 107.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA C 305 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 455 O REMARK 620 2 GLU C 173 OE1 110.5 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7ZS7 RELATED DB: PDB REMARK 900 7ZS7 CONTAINS THE SAME PROTEIN COMPLEXED WITH CALPAIN INHIBITOR VI DBREF 7ZVF A 1 220 UNP P07711 CATL1_HUMAN 114 333 DBREF 7ZVF B 1 220 UNP P07711 CATL1_HUMAN 114 333 DBREF 7ZVF C 1 220 UNP P07711 CATL1_HUMAN 114 333 DBREF 7ZVF D 1 220 UNP P07711 CATL1_HUMAN 114 333 SEQADV 7ZVF ALA A 110 UNP P07711 THR 223 ENGINEERED MUTATION SEQADV 7ZVF ALA B 110 UNP P07711 THR 223 ENGINEERED MUTATION SEQADV 7ZVF ALA C 110 UNP P07711 THR 223 ENGINEERED MUTATION SEQADV 7ZVF ALA D 110 UNP P07711 THR 223 ENGINEERED MUTATION SEQRES 1 A 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 A 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 A 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 A 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 A 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 A 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 A 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 A 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 A 220 SER VAL ALA ASN ASP ALA GLY PHE VAL ASP ILE PRO LYS SEQRES 10 A 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 A 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 A 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 A 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 A 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 A 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 A 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 A 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL SEQRES 1 B 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 B 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 B 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 B 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 B 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 B 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 B 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 B 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 B 220 SER VAL ALA ASN ASP ALA GLY PHE VAL ASP ILE PRO LYS SEQRES 10 B 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 B 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 B 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 B 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 B 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 B 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 B 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 B 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL SEQRES 1 C 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 C 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 C 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 C 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 C 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 C 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 C 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 C 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 C 220 SER VAL ALA ASN ASP ALA GLY PHE VAL ASP ILE PRO LYS SEQRES 10 C 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 C 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 C 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 C 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 C 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 C 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 C 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 C 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL SEQRES 1 D 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 D 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 D 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 D 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 D 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 D 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 D 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 D 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 D 220 SER VAL ALA ASN ASP ALA GLY PHE VAL ASP ILE PRO LYS SEQRES 10 D 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 D 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 D 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 D 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 D 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 D 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 D 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 D 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL HET KXL A 301 57 HET PG4 A 302 31 HET 1PE A 303 38 HET DMS A 304 10 HET DMS A 305 10 HET PEG A 306 17 HET PEG A 307 17 HET PEG A 308 17 HET KXL B 301 57 HET DMS B 302 10 HET DMS B 303 10 HET 1PE B 304 38 HET NA B 305 1 HET KXL C 301 57 HET PEG C 302 17 HET 1PE C 303 38 HET EDO C 304 10 HET NA C 305 1 HET KXL D 301 57 HET PEG D 302 17 HET PEG D 303 17 HET PEG D 304 17 HET PEG D 305 17 HET 1PE D 306 38 HET DMS D 307 10 HET DMS D 308 10 HET DMS D 309 10 HETNAM KXL (2S)-N-[(2S)-1-(DIMETHYLAMINO)-1-OXIDANYLIDENE-3- HETNAM 2 KXL PHENYL-PROPAN-2-YL]-2-OXIDANYL-N'-(2-PYRIDIN-2- HETNAM 3 KXL YLETHYL)BUTANEDIAMIDE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1PE PENTAETHYLENE GLYCOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM NA SODIUM ION HETNAM EDO 1,2-ETHANEDIOL HETSYN 1PE PEG400 HETSYN EDO ETHYLENE GLYCOL FORMUL 5 KXL 4(C22 H28 N4 O4) FORMUL 6 PG4 C8 H18 O5 FORMUL 7 1PE 4(C10 H22 O6) FORMUL 8 DMS 7(C2 H6 O S) FORMUL 10 PEG 8(C4 H10 O3) FORMUL 17 NA 2(NA 1+) FORMUL 21 EDO C2 H6 O2 FORMUL 32 HOH *497(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 SER A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 GLY A 58 GLY A 61 5 4 HELIX 5 AA5 GLU A 63 GLY A 67 5 5 HELIX 6 AA6 LEU A 69 GLY A 81 1 13 HELIX 7 AA7 ASN A 101 LYS A 103 5 3 HELIX 8 AA8 GLN A 118 VAL A 129 1 12 HELIX 9 AA9 HIS A 140 TYR A 146 1 7 HELIX 10 AB1 ASN A 207 ILE A 211 5 5 HELIX 11 AB2 ARG B 8 GLY B 11 5 4 HELIX 12 AB3 SER B 24 GLY B 43 1 20 HELIX 13 AB4 SER B 49 SER B 57 1 9 HELIX 14 AB5 GLY B 58 GLY B 61 5 4 HELIX 15 AB6 GLU B 63 GLY B 67 5 5 HELIX 16 AB7 LEU B 69 GLY B 81 1 13 HELIX 17 AB8 ASN B 101 LYS B 103 5 3 HELIX 18 AB9 GLN B 118 VAL B 129 1 12 HELIX 19 AC1 HIS B 140 PHE B 145 1 6 HELIX 20 AC2 ASN B 207 ILE B 211 5 5 HELIX 21 AC3 SER C 24 GLY C 43 1 20 HELIX 22 AC4 SER C 49 SER C 57 1 9 HELIX 23 AC5 GLY C 58 GLY C 61 5 4 HELIX 24 AC6 GLU C 63 GLY C 67 5 5 HELIX 25 AC7 LEU C 69 GLY C 81 1 13 HELIX 26 AC8 ASN C 101 LYS C 103 5 3 HELIX 27 AC9 GLN C 118 GLY C 130 1 13 HELIX 28 AD1 HIS C 140 PHE C 145 1 6 HELIX 29 AD2 ASN C 207 ILE C 211 5 5 HELIX 30 AD3 ARG D 8 GLY D 11 5 4 HELIX 31 AD4 SER D 24 GLY D 43 1 20 HELIX 32 AD5 SER D 49 SER D 57 1 9 HELIX 33 AD6 GLY D 58 GLY D 61 5 4 HELIX 34 AD7 GLU D 63 GLY D 67 5 5 HELIX 35 AD8 LEU D 69 GLY D 81 1 13 HELIX 36 AD9 ASN D 101 LYS D 103 5 3 HELIX 37 AE1 GLN D 118 GLY D 130 1 13 HELIX 38 AE2 HIS D 140 PHE D 145 1 6 HELIX 39 AE3 THR D 175 ASN D 179 5 5 HELIX 40 AE4 ASN D 207 ILE D 211 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 HIS A 163 PHE A 172 -1 O TYR A 170 N VAL A 5 SHEET 3 AA1 3 ILE A 132 ILE A 136 -1 N ILE A 132 O VAL A 167 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 163 PHE A 172 -1 O TYR A 170 N VAL A 5 SHEET 3 AA2 5 LYS A 181 LYS A 186 -1 O LYS A 186 N LEU A 166 SHEET 4 AA2 5 TYR A 198 ALA A 202 -1 O MET A 201 N TRP A 183 SHEET 5 AA2 5 ILE A 150 TYR A 151 1 N TYR A 151 O LYS A 200 SHEET 1 AA3 2 LEU A 83 ASP A 84 0 SHEET 2 AA3 2 SER A 105 ALA A 107 -1 O VAL A 106 N LEU A 83 SHEET 1 AA4 2 PHE A 112 ASP A 114 0 SHEET 2 AA4 2 SER A 216 PRO A 218 -1 O TYR A 217 N VAL A 113 SHEET 1 AA5 3 VAL B 5 ASP B 6 0 SHEET 2 AA5 3 HIS B 163 GLY B 171 -1 O TYR B 170 N VAL B 5 SHEET 3 AA5 3 ILE B 132 ILE B 136 -1 N VAL B 134 O VAL B 165 SHEET 1 AA6 5 VAL B 5 ASP B 6 0 SHEET 2 AA6 5 HIS B 163 GLY B 171 -1 O TYR B 170 N VAL B 5 SHEET 3 AA6 5 TYR B 182 LYS B 186 -1 O LYS B 186 N LEU B 166 SHEET 4 AA6 5 TYR B 198 ALA B 202 -1 O MET B 201 N TRP B 183 SHEET 5 AA6 5 ILE B 150 TYR B 151 1 N TYR B 151 O LYS B 200 SHEET 1 AA7 2 LEU B 83 ASP B 84 0 SHEET 2 AA7 2 SER B 105 ALA B 107 -1 O VAL B 106 N LEU B 83 SHEET 1 AA8 2 PHE B 112 ASP B 114 0 SHEET 2 AA8 2 SER B 216 PRO B 218 -1 O TYR B 217 N VAL B 113 SHEET 1 AA9 3 VAL C 5 ASP C 6 0 SHEET 2 AA9 3 HIS C 163 GLY C 171 -1 O TYR C 170 N VAL C 5 SHEET 3 AA9 3 ILE C 132 ILE C 136 -1 N VAL C 134 O VAL C 165 SHEET 1 AB1 5 VAL C 5 ASP C 6 0 SHEET 2 AB1 5 HIS C 163 GLY C 171 -1 O TYR C 170 N VAL C 5 SHEET 3 AB1 5 LYS C 181 LYS C 186 -1 O LYS C 186 N LEU C 166 SHEET 4 AB1 5 TYR C 198 LYS C 203 -1 O MET C 201 N TRP C 183 SHEET 5 AB1 5 ILE C 150 TYR C 151 1 N TYR C 151 O LYS C 200 SHEET 1 AB2 2 LEU C 83 ASP C 84 0 SHEET 2 AB2 2 SER C 105 ALA C 107 -1 O VAL C 106 N LEU C 83 SHEET 1 AB3 2 PHE C 112 ASP C 114 0 SHEET 2 AB3 2 SER C 216 PRO C 218 -1 O TYR C 217 N VAL C 113 SHEET 1 AB4 3 VAL D 5 ASP D 6 0 SHEET 2 AB4 3 HIS D 163 PHE D 172 -1 O TYR D 170 N VAL D 5 SHEET 3 AB4 3 ILE D 132 ILE D 136 -1 N VAL D 134 O VAL D 165 SHEET 1 AB5 5 VAL D 5 ASP D 6 0 SHEET 2 AB5 5 HIS D 163 PHE D 172 -1 O TYR D 170 N VAL D 5 SHEET 3 AB5 5 LYS D 181 LYS D 186 -1 O LYS D 186 N LEU D 166 SHEET 4 AB5 5 TYR D 198 ALA D 202 -1 O MET D 201 N TRP D 183 SHEET 5 AB5 5 ILE D 150 TYR D 151 1 N TYR D 151 O LYS D 200 SHEET 1 AB6 2 LEU D 83 ASP D 84 0 SHEET 2 AB6 2 SER D 105 ALA D 107 -1 O VAL D 106 N LEU D 83 SHEET 1 AB7 2 PHE D 112 ASP D 114 0 SHEET 2 AB7 2 SER D 216 PRO D 218 -1 O TYR D 217 N VAL D 113 SSBOND 1 CYS A 22 CYS A 65 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 98 1555 1555 2.05 SSBOND 3 CYS A 156 CYS A 209 1555 1555 1.99 SSBOND 4 CYS B 22 CYS B 65 1555 1555 2.08 SSBOND 5 CYS B 56 CYS B 98 1555 1555 2.04 SSBOND 6 CYS B 156 CYS B 209 1555 1555 2.07 SSBOND 7 CYS C 22 CYS C 65 1555 1555 2.06 SSBOND 8 CYS C 56 CYS C 98 1555 1555 2.04 SSBOND 9 CYS C 156 CYS C 209 1555 1555 2.03 SSBOND 10 CYS D 22 CYS D 65 1555 1555 2.05 SSBOND 11 CYS D 56 CYS D 98 1555 1555 2.03 SSBOND 12 CYS D 156 CYS D 209 1555 1555 2.00 LINK SG CYS A 25 C10 KXL A 301 1555 1555 1.75 LINK SG CYS B 25 C10 KXL B 301 1555 1555 1.80 LINK SG CYS C 25 C10 KXL C 301 1555 1555 1.80 LINK SG CYS D 25 C10 KXL D 301 1555 1555 1.75 LINK OD2 ASP A 178 NA NA B 305 1555 1555 2.38 LINK OE1 GLN B 75 NA NA B 305 1555 1555 2.42 LINK OE1 GLN B 78 NA NA B 305 1555 1555 2.60 LINK O HOH B 455 NA NA C 305 1455 1555 2.71 LINK OE1 GLU C 173 NA NA C 305 1555 1555 2.41 CRYST1 57.220 62.290 68.030 105.53 93.56 115.73 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017476 0.008420 0.004072 0.00000 SCALE2 0.000000 0.017820 0.006181 0.00000 SCALE3 0.000000 0.000000 0.015589 0.00000